These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11361624)

  • 1. Pentafuside shows anti-HIV activity.
    AIDS Patient Care STDS; 1996 Jun; 10(3):184. PubMed ID: 11361624
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentafuside effective.
    AIDS Patient Care STDS; 1996 Apr; 10(2):130. PubMed ID: 11361691
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV fusion inhibitors.
    Pozniak A
    J HIV Ther; 2001 Nov; 6(4):91-4. PubMed ID: 11740409
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentafuside. DP 178, T 20.
    Drugs R D; 1999 Nov; 2(5):347-9. PubMed ID: 10728478
    [No Abstract]   [Full Text] [Related]  

  • 5. T-20 and Trimeris.
    James JS
    AIDS Treat News; 1998 Apr; (No 293):1-6. PubMed ID: 11365387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimeris, Roche pull no-needle Fuzeon bid.
    AIDS Read; 2007 Dec; 17(12):581. PubMed ID: 18178973
    [No Abstract]   [Full Text] [Related]  

  • 8. [HIV infections: further options for combination therapy].
    Hildegard K
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1523. PubMed ID: 12899165
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS. Still no vaccine, but better antiviral drugs are on the way.
    Park A
    Time; 2001 Jan; 157(2):70-2. PubMed ID: 11195691
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs show promise in attacking HIV.
    Dent Today; 2002 Dec; 21(12):30. PubMed ID: 12572158
    [No Abstract]   [Full Text] [Related]  

  • 11. What's taking T-20 so long?
    Huff B
    GMHC Treat Issues; 2001 Apr; 15(4):1-3. PubMed ID: 11590938
    [No Abstract]   [Full Text] [Related]  

  • 12. US FDA approves new class of HIV therapeutics.
    Robertson D
    Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS researchers seek criteria for vaccines.
    Check E
    Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
    [No Abstract]   [Full Text] [Related]  

  • 14. T-20 continues to look promising.
    AIDS Patient Care STDS; 1999 Dec; 13(12):753. PubMed ID: 10743540
    [No Abstract]   [Full Text] [Related]  

  • 15. First fusion inhibitor for advanced HIV.
    Am J Nurs; 2003 Jul; 103(7):64F. PubMed ID: 12877130
    [No Abstract]   [Full Text] [Related]  

  • 16. Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells.
    Otaka A; Nakamura M; Nameki D; Kodama E; Uchiyama S; Nakamura S; Nakano H; Tamamura H; Kobayashi Y; Matsuoka M; Fujii N
    Angew Chem Int Ed Engl; 2002 Aug; 41(16):2937-40. PubMed ID: 12203417
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV entry inhibitors: a new generation of antiretroviral drugs.
    Krambovitis E; Porichis F; Spandidos DA
    Acta Pharmacol Sin; 2005 Oct; 26(10):1165-73. PubMed ID: 16174430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV genetic mutations causing resistance to the new drug T-20: recent findings.
    Bean P
    Am Clin Lab; 2002 Oct; 21(8):15-6. PubMed ID: 12440170
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.
    Barretina J; Blanco J; Armand-Ugón M; Gutiérrez A; Clotet B; Esté JA
    Antivir Ther; 2003 Apr; 8(2):155-61. PubMed ID: 12741628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-20 (Fuzeon) gets priority review.
    AIDS Treat News; 2002 Oct; (384):4-5. PubMed ID: 12434762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.